D-0297-2023 Class II Terminated
FDA drug recall D-0297-2023 was initiated by Sentara Infusion Services on Dec 27, 2022 and is designated Class II. Reason for recall: Lack of sterility assurance The recall status is terminated (terminated Feb 20, 2026). Affected quantity: 7 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Feb 22, 2023
- Initiation Date
- Dec 27, 2022
- Termination Date
- Feb 20, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7 bags
Product Description
IMIPENEM/CILASTATIN 2000MG IN NS 400ML, antibiotic, Rx Only, use with a Curlin Pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320, NDC# 63323-0322-25
Reason for Recall
Lack of sterility assurance
Distribution Pattern
Dispensed to Patients Nationwide.
Code Information
Beyond Use Date: December 25-30, 2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0297-2023
- openFDA file date
- Oct 21, 2026
- Loaded by RegDataLab
- Oct 23, 2026